lancet-header

Preprints with The Lancet is a collaboration between The Lancet Group of journals and SSRN to facilitate the open sharing of preprints for early engagement, community comment, and collaboration. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early-stage research papers that have not been peer-reviewed. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. The findings should not be used for clinical or public health decision-making or presented without highlighting these facts. For more information, please see the FAQs.

Attributable Deaths of Liver Cancer in China

18 Pages Posted: 7 Apr 2021

See all articles by Maomao Cao

Maomao Cao

Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Office of Cancer Screening

Chao Ding

Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Anesthesiology

Changfa Xia

Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Epidemiology

He Li

Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Office of Cancer Screening

Dianqin Sun

Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Office of Cancer Screening

Siyi He

Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Office of Cancer Screening

Wanqing Chen

Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Office of Cancer Screening

More...

Abstract

Background: Several risk factors of liver cancer have been identified through a number of epidemiological studies. However, there is little information about the contributions of these risk factors to liver cancer burden. We conducted a comparative study to estimate the liver cancer burden attributable to major risk factors of liver cancer deaths.  

Methods: Liver cancer deaths for adults were estimated from 978 county-level surveillance points in China in 2014. Risk factors were identified from the International Agency for Research on Cancer and the World Cancer Research Fund International. Exposure prevalence of the studied risk factors was acquired from national representative surveys in China with a 10-year lag-period. Relative risks were obtained from recent high-quality meta-analyses in China. Population attributable fraction (PAF) by age, sex, and province was calculated using multiple formulas.  

Findings: In China, 318 698 deaths from liver cancer were estimated, and 230 856 deaths were attributable to the studied risk factors, with a PAF of 72·4%. Hepatitis B virus (HBV) was responsible for the largest fraction of liver cancer burden in both genders (PAF=55·6% in males, and PAF=46·5% in females), followed by Hepatitis C virus (HCV) (PAF=17·4% in males, and PAF=15·9% in females). The PAFs for liver cancer burden in males attributable to smoking (PAF=15·7%), and alcohol drinking (PAF=10·3%) were significantly higher than in females (PAF=4·8% for smoking and PAF=1·6% for alcohol drinking). PAFs of HBV for liver cancer were particularly high across all age groups. The burden of HBV-attributable deaths was highest in Qinghai Province.  

Interpretation: HBV still contributes to the majority of liver cancer burden than any other risk factors. Targeted preventive measures should be implemented based on the degree of contributions of different risk factors to liver cancer deaths.  

Funding: This study was supported by the National Natural Science Foundation of China (81974492), Major State Basic Innovation Program of the Chinese Academy of Medical Sciences (2019-I2M-2-004), Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences (2019PT320027), and Sanming Project of Medicine in Shenzhen (SZSM201911015).

Declaration of Interest: None to declare.

Suggested Citation

Cao, Maomao and Ding, Chao and Xia, Changfa and Li, He and Sun, Dianqin and He, Siyi and Chen, Wanqing, Attributable Deaths of Liver Cancer in China (4/1/2021). Available at SSRN: https://ssrn.com/abstract=3821794 or http://dx.doi.org/10.2139/ssrn.3821794

Maomao Cao

Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Office of Cancer Screening

Beijing
China

Chao Ding

Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Anesthesiology

Panjiayuan 17#, Chaoyang District, Beijing, 100021
Beijing, 100021
China

Changfa Xia

Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Epidemiology ( email )

Panjiayuan 17#, Chaoyang District, Beijing, 100021
Beijing, 100021
China

He Li

Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Office of Cancer Screening

Beijing
China

Dianqin Sun

Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Office of Cancer Screening

Beijing
China

Siyi He

Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Office of Cancer Screening

Beijing
China

Wanqing Chen (Contact Author)

Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Office of Cancer Screening ( email )

Beijing
China